Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile. The Chilean National Committee for Meningococcal Disease.
Zollinger
W D
WD
Boslego
J
J
Moran
E
E
Garcia
J
J
Cruz
C
C
Ruiz
S
S
Brandt
B
B
Martinez
M
M
Arthur
J
J
Underwood
P
P
D000293:Adolescent; D000328:Adult; D000907:Antibodies, Bacterial / Q000097:blood / Q000276:immunology; D000917:Antibody Formation; D016667:Bacterial Capsules; D001425:Bacterial Outer Membrane Proteins / Q000276:immunology*; D001428:Bacterial Vaccines / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002677:Chile; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D022401:Meningococcal Vaccines; D011135:Polysaccharides, Bacterial / Q000276:immunology*
D000907:Antibodies, Bacterial; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D022401:Meningococcal Vaccines; D011135:Polysaccharides, Bacterial; C039455:capsular polysaccharide, meningococcal group B